China's securities regulator has begun tightening approval standards for humanoid robotics startups seeking public listings, according to informal guidance issued to investment banks.
The China Securities Regulatory Commission (CSRC) is now requiring companies to demonstrate recurring revenue streams and a clear path to narrower losses or substantial innovation before advancing IPO applications. The move marks a sharp reversal from the sector's prior regulatory permissiveness.
The shift follows Unitree Robotics' turbulent Shanghai debut. The company's stock surged more than fivefold on its first day, then collapsed 45 percent, exposing the speculative fervor that has gripped China's robotics market.
The whipsaw has alarmed regulators. Officials worry the sector is inflating into a bubble—particularly concerning given a 2026 private funding frenzy that flooded unlisted robotics ventures with capital. A deep pipeline of IPO filings from robotics startups added urgency to the CSRC's decision.
The guidance remains informal, and the CSRC has not officially verified details or responded to requests for comment.
Robotera, another Chinese humanoid robotics maker, is reportedly weighing a Hong Kong IPO that could raise $800 million to $1 billion, valuing the company at $1.4 billion. The regulatory shift will likely constrain its timeline and force clearer disclosure of path-to-profitability metrics.
